Covered recipient · General Payments record
COLTON GARRETT HOFFER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2025
$2,329.16
- Reported across 66 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,377.39 | 35 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $448.42 | 8 |
| Amgen Inc. | $413.97 | 11 |
| GENZYME CORPORATION | $142.19 | 1 |
| GlaxoSmithKline, LLC. | $91.52 | 4 |
| Acerta Pharma LLC | $57.89 | 3 |
| UCB, Inc. | $57.43 | 2 |
| PFIZER INC. | $43.92 | 2 |
| SOBI, INC | $43.67 | 1 |
| Lilly USA, LLC | $34.00 | 1 |
| Aurinia Pharma U.S., Inc. | $25.50 | 1 |
| Janssen Biotech, Inc. | $18.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2025 2021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.42 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053420 | CMS |
| ABBVIE INC. | $112.54 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053422 | CMS |
| ABBVIE INC. | $24.70 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053424 | CMS |
| ABBVIE INC. | $146.41 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053426 | CMS |
| ABBVIE INC. | $33.70 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053428 | CMS |
| ABBVIE INC. | $21.77 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053430 | CMS |
| ABBVIE INC. | $55.99 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053432 | CMS |
| ABBVIE INC. | $29.89 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202053434 | CMS |
| Amgen Inc. | $26.18 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396462 | CMS |
| Amgen Inc. | $20.29 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396464 | CMS |
| Amgen Inc. | $17.11 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396478 | CMS |
| Amgen Inc. | $29.96 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396460 | CMS |
| Amgen Inc. | $140.89 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396466 | CMS |
| Amgen Inc. | $27.30 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396470 | CMS |
| Amgen Inc. | $34.45 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396468 | CMS |
| Amgen Inc. | $28.70 | 10/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396458 | CMS |
| Amgen Inc. | $31.44 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396474 | CMS |
| Amgen Inc. | $33.44 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396472 | CMS |
| Amgen Inc. | $24.21 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396476 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.62 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206256692 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.08 | 05/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206300683 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.19 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206715627 | CMS |
| Aurinia Pharma U.S., Inc. | $25.50 | 05/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249405990 | CMS |
| GENZYME CORPORATION | $142.19 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233398278 | CMS |
| GlaxoSmithKline, LLC. | $34.90 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191437925 | CMS |
| GlaxoSmithKline, LLC. | $23.01 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191578726 | CMS |
| GlaxoSmithKline, LLC. | $15.09 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190668654 | CMS |
| GlaxoSmithKline, LLC. | $18.52 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190900300 | CMS |
| Janssen Biotech, Inc. | $18.88 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175353539 | CMS |
| Lilly USA, LLC | $34.00 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186595632 | CMS |
| PFIZER INC. | $18.10 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231615092 | CMS |
| PFIZER INC. | $25.82 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231283932 | CMS |
| SOBI, INC | $43.67 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240236689 | CMS |
| UCB, Inc. | $28.05 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224559504 | CMS |
| UCB, Inc. | $29.38 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224560091 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.